Investigator Initiated Clinical Trials

Led by the Cancer Research Society, with the Terry Fox Research Institute and Canadian Cancer Society as co-leads, this first-ever national program aims to empower Canadian doctors and researchers to design and conduct cutting-edge clinical trials. The program aims to foster the development of innovative treatments, improve patient care, and address priority clinical questions, including those related to rare and understudied cancers.